Moore, Kathleen N.; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Anderson, Charles; Scambia, Giovanni; Myers, Tashanna; Taskiran, Cagatay; Robison, Katina; Mäenpää, Johanna; Willmott, Lyndsay; Colombo, Nicoletta; Thomes-Pepin, Jessica; Liontos, Michalis; Gold, Michael A.; Garcia, Yolanda; Sharma, Sudarshan K.; Darus, Christopher J.; Aghajanian, Carol; Okamoto, Aikou; Wu, Xiaohua; Safin, Rustem; Wu, Fan; Molinero, Luciana; Maiya, Vidya; Khor, Victor K.; Lin, Yvonne G.; Pignata, Sandro (2021)
article
PURPOSE: To evaluate the addition of the humanized monoclonal antiprogrammed death ligand-1 (PD-L1) antibody, atezolizumab, to platinum-based chemotherapy and bevacizumab in newly diagnosed stage III or IV ovarian cancer ...